TY - JOUR
T1 - Tobacco treatment programs at National Cancer Institute-designated cancer centers
T2 - A systematic review and online audit
AU - Day, Andrew T.
AU - Tang, Liyang
AU - Karam-Hage, Maher
AU - Fakhry, Carole
N1 - Publisher Copyright:
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Objectives: The main objectives of this study were to evaluate abstinence rates of tobacco treatment programs (TTPs) at National Cancer Institute (NCI)-designated cancer centers (DCCs) and to ascertain the number of NCI-DCCs with online references to TTPs. Methods: Literature searches of Pubmed, EMBASE, Web of Science, and Scopus were performed from their inception through January 2018 using keywords including cancer patients, cancer survivors, tobacco, smoking, cessation, and program. In total, 4094 articles were identified, 1450 duplicates were removed, 2644 candidate titles and abstracts were screened, and 210 selected full-text articles were independently reviewed by 2 authors. Three retrospective, single-institution cohort studies describing system-wide TTPs at 3 NCI-DCCs met inclusion criteria. Secondarily, online website audits of each NCI-DCC were performed to identify institutions with online evidence of a system-wide TTP servicing cancer patients. Results: Among 62 NCI-DCCs, only 3 reported system-wide TTP outcomes. Abstinence rates ranged from 15% to 47%. Online website audit identified 47 NCI-DCCs maintaining system-wide TTPs. Seventeen TTPs were housed within the cancer center and 30 TTPs were offered by the primary affiliated institution; among the latter group, only 13 TTPs were identifiable via the NCI-DCC webpage. Conclusions: Most NCI-DCCs offer tobacco treatment services to cancer patients but very few have reported their results. Increased NCIDCC TTP outcome publication and online presence are needed.
AB - Objectives: The main objectives of this study were to evaluate abstinence rates of tobacco treatment programs (TTPs) at National Cancer Institute (NCI)-designated cancer centers (DCCs) and to ascertain the number of NCI-DCCs with online references to TTPs. Methods: Literature searches of Pubmed, EMBASE, Web of Science, and Scopus were performed from their inception through January 2018 using keywords including cancer patients, cancer survivors, tobacco, smoking, cessation, and program. In total, 4094 articles were identified, 1450 duplicates were removed, 2644 candidate titles and abstracts were screened, and 210 selected full-text articles were independently reviewed by 2 authors. Three retrospective, single-institution cohort studies describing system-wide TTPs at 3 NCI-DCCs met inclusion criteria. Secondarily, online website audits of each NCI-DCC were performed to identify institutions with online evidence of a system-wide TTP servicing cancer patients. Results: Among 62 NCI-DCCs, only 3 reported system-wide TTP outcomes. Abstinence rates ranged from 15% to 47%. Online website audit identified 47 NCI-DCCs maintaining system-wide TTPs. Seventeen TTPs were housed within the cancer center and 30 TTPs were offered by the primary affiliated institution; among the latter group, only 13 TTPs were identifiable via the NCI-DCC webpage. Conclusions: Most NCI-DCCs offer tobacco treatment services to cancer patients but very few have reported their results. Increased NCIDCC TTP outcome publication and online presence are needed.
KW - Cancer center
KW - National Cancer Institute
KW - Smoking cessation
KW - Tobacco dependence
KW - Tobacco treatment
UR - http://www.scopus.com/inward/record.url?scp=85063713384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063713384&partnerID=8YFLogxK
U2 - 10.1097/COC.0000000000000522
DO - 10.1097/COC.0000000000000522
M3 - Review article
C2 - 30724778
AN - SCOPUS:85063713384
SN - 0277-3732
VL - 42
SP - 407
EP - 410
JO - American Journal of Clinical Oncology: Cancer Clinical Trials
JF - American Journal of Clinical Oncology: Cancer Clinical Trials
IS - 4
ER -